Leerink Partners Maintains Affimed NV(AFMD.US) With Buy Rating, Cuts Target Price to $5
H.C. Wainwright Maintains Affimed NV(AFMD.US) With Buy Rating, Maintains Target Price $7
Truist Financial Maintains Affimed NV(AFMD.US) With Buy Rating
H.C. Wainwright Maintains Affimed NV(AFMD.US) With Buy Rating, Cuts Target Price to $7
Wells Fargo Maintains Affimed NV(AFMD.US) With Buy Rating, Cuts Target Price to $11
Affimed Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Affimed NV(AFMD.US) With Buy Rating, Cuts Target Price to $15
Affimed Analyst Ratings
H.C. Wainwright Maintains Affimed NV(AFMD.US) With Buy Rating, Maintains Target Price $10
Stifel Maintains Affimed NV(AFMD.US) With Hold Rating, Cuts Target Price to $4
Affimed Is Maintained at Hold by Stifel
Affimed Analyst Ratings
H.C. Wainwright Maintains Affimed NV(AFMD.US) With Buy Rating, Maintains Target Price $10
Truist Financial Maintains Affimed NV(AFMD.US) With Buy Rating
Truist Financial Maintains Affimed NV(AFMD.US) With Buy Rating
Stifel Maintains Affimed NV(AFMD.US) With Hold Rating, Maintains Target Price $5
Truist Financial Maintains Affimed NV(AFMD.US) With Buy Rating
H.C. Wainwright Maintains Affimed NV(AFMD.US) With Buy Rating, Maintains Target Price $10
HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $10 Price Target
Affimed Analyst Ratings